Morningstar says Australian Cochlear's FY27 profit growth target looks "too ambitious"

By Reuters News

** Morningstar maintains A$110 fair value estimate on Australia's Cochlear COH.AX

** Investment research firm says the hearing implants maker's new medium-term target of about 10% annual underlying net profit growth is "aggressive" and unlikely to be met

** Co reaffirmed on Friday its FY2027 underlying net profit forecast of A$330 million to A$350 million ($222.78 mln to $236.29 mln)

** Morningstar expects co's revenue and profit to grow at about 5% annually through FY2031

** Estimates current share price of nearly 40% above intrinsic assessment implies revenue growth of about 8% annually for five years and net margin of around 18% versus Morningstar forecasts of about 6% revenue growth and 14% net margin

** 14 of 16 analysts rate the stock "hold" and two "sell"; their median PT is A$138.21, LSEG data

** YTD, stock down 42.1% as of last close


($1 = 1.4813 Australian dollars)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.